This message was sent to ##Email##
|
|
|
|
|
Cancer Therapy Advisor
An integrative model incorporating cancer care into primary care is recommended for addressing the increasing burden of cancer control, according to a commission piece published in The Lancet Oncology.
Noting that cancer control is increasingly emphasizing prevention, early diagnosis, and patient experience during and after treatment, Greg Rubin, M.B.B.S., from Durham University in the United Kingdom, and colleagues discuss the expanding role of primary care in cancer control.
READ MORE
Healio
Proflavine staining and confocal fluorescence microscopy in combination with image analysis strategies to segment morphological features may diagnose breast cancer in fresh breast tissue without a pathologist, according to study results.
READ MORE
U.S. News & World Report
John Ryan was running out of options. Four rounds of chemotherapy had left him severely debilitated but had failed to control his lung cancer, which had now spread to his ribs and hip. The pain was unremitting, he could barely eat and he was so weakened from chemo he couldn't muster the energy to walk down his driveway. "The tumors were progressing exponentially," recalls the 71-year-old retiree, a nonsmoker who spent much of his nearly 30-year Navy career working on nuclear submarines. "And I was devastated." An experimental drug offered his only hope.
READ MORE
University of Texas Medical Branch at Galveston via Medical Xpress
A new population-based study from The University of Texas Medical Branch at Galveston showed for the first time that exposure to testosterone therapy over a five-year period was not associated with an increased risk of aggressive prostate cancer. Further, risk of high-grade prostate cancer did not increase according to the total number of testosterone injections. The study is available in the Journal of Urology.
READ MORE
| NAPBC and CoC provide online poster to observe Breast Cancer Awareness Month
|
    |
ACS
October is Breast Cancer Awareness Month. The National Accreditation Program for Breast Centers (NAPBC) and the Commission on Cancer (CoC) encourage your program to promote the event and use it as an opportunity to display/promote your accreditation status. To help you publicize this event within your program and the community, the NAPBC and the CoC have created a poster that you can download and print. Programs that are solely CoC accredited or accredited by both the CoC and NAPBC can access the poster by logging into CoC Datalinks and clicking on Marketing Resources Staff and NAPBC-accredited breast centers can log into the NAPBC portal and click on the "2015 Breast Cancer Awareness Month Poster" link in the "View Downloadable Center Resources" section to access the marketing resources Web page. For more information, contact srubin@facs.org.
PRODUCT SHOWCASE
 |
|
NCBC is certifying breast patient Navigators on every coast. If you’ve ever wanted to validate your skills in navigation, now is your chance. In November, a review course and a breast patient navigator exam will be offered on consecutive days in Albuquerque, NM. Check out the schedule of events.
|
|
WebMD
Antiretroviral therapy has extended the lives of people with HIV, but living longer may increase these patients' risk for certain cancers.
A study of nearly 90,000 HIV patients revealed a rise in three types of cancer as the AIDS-causing virus has evolved from a probable death sentence into a manageable chronic condition.
READ MORE
HealthDay
Teen and young adult cancer survivors are at increased risk for other cancers later in life, a new study reveals.
Researchers analyzed U.S. National Cancer Institute data on people who survived cancers before age 40. They had the most common types of cancers in that age group: leukemia, lymphoma, testicular, ovarian, thyroid, breast, soft tissue and bone cancers.
READ MORE
 |
|
CHAMPS Oncology’s new web-based system transforms cancer data into actionable information for strategic planning, operational and financial decisions.
• CHAMPS Seeks i2o™ Early Adopters
• i2o™ Provides Answers to Cancer Service Lines’ Questions
• Access 75+ Cancer Data Reports (Migration, Utilization & More)
|
|
Medical News Today
Cancer cells have a nutrient-sensing mechanism that helps them compete with other types of cell for food to fuel growth. Now, new research suggests targeting PAT4 — a protein that supports this mechanism — could be a way to stop tumors growing.
READ MORE
The Dallas Morning News
Using tiny but powerful bursts of electricity to make holes in pancreatic cancer cells may improve survival rates for some patients, new research suggests.
Using zaps of electricity in certain patients can "nearly double the survival rate with the best new chemotherapy and chemo-radiotherapy," said study author Dr. Robert Martin II, director of surgical oncology at the University of Louisville.
READ MORE
ACS
Register to attend the ACS Clinical Congress in Chicago, Oct. 4-8, and you can preorder the Webcasts today. This year's Clinical Congress includes more than 15 panel sessions in the Surgical Oncology Track that cover a variety of topics. For detailed information, please visit the Clinical Congress 2015 Web page.
Note: Webcasts will be made available after Nov. 15. Purchase provides access to the 2015 Webcast sessions and expires Dec. 31, 2016.
READ MORE
U.S. News & World Report
The pink ribbons that abound in October have come to symbolize breast cancer awareness and celebrate cancer survivorship. However, these ribbons should also serve as a reminder of the work that needs to be done to address the emotional impact of cancer. Around 40 percent of those living with cancer experience significant emotional distress, including feelings of depression and anxiety. While research also tells us that most people who are post-treatment are no more likely to experience psychological distress than those who haven't been through cancer, post-treatment can be a vulnerable time for cancer survivors, with signs of depression often going unrecognized and untreated.
READ MORE
Universitat Autònoma de Barcelona via Medical Xpress
Universitat Autònoma de Barcelona researchers have found a mycobacterium that is more effective in treating superficial bladder cancer and does not cause infections, unlike those used up to now. Mycobacteria are the only bacteria used in cancer treatment. The administration of the bacterium Mycobacterium bovis, is the current treatment for superficial bladder cancer. It is inserted directly into the bladder through a catheter. BCG prevents new tumors from appearing, but despite its efficacy it has many adverse side effects, the most serious being BCG infections that need to be treated with antituberculous drugs.
READ MORE
ACS
On Nov. 14, the National Accreditation Program for Breast Centers (NAPBC) will hold the Pursuing Excellence through NAPBC Accreditation workshop in Chicago at the American College of Surgeons' Headquarters. If you are applying for NAPBC accreditation or preparing for an initial or re-accreditation survey, this program is a must-attend. The National Cancer Registrars Association Program Recognition Committee has determined the Pursuing Excellence through NAPBC Accreditation program supports six CE hours. Contact the NAPBC for additional information.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
